Harrow, Inc. Notes Payable, Noncurrent
Harrow, Inc. (HROW) had Notes Payable, Noncurrent of $292.38 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2026-08-10
- 2026-06-30: Notes Payable, Noncurrent $292.38M.
- 2026-03-31: Notes Payable, Noncurrent $292.09M.
- 2025-12-31: Notes Payable, Noncurrent $243.18M.
- 2025-09-30: Notes Payable, Noncurrent $242.87M.
| Period end | Notes Payable, Noncurrent | Notes Payable, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $292.38M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $292.09M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $243.18M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $242.87M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $38.48M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $112.50M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $219.54M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $186.06M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $185.02M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $184.15M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $185.88M 10-K · filed 2025-03-27 | $183.17M 10-K · filed 2024-03-19 |
| 2023-09-30 | $182.19M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $169.71M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $168.85M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $104.17M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $72.24M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $72.04M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $71.85M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $71.65M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $71.46M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $71.27M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $11.00M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $12.38M 10-K · filed 2022-03-10 | $11.67M 10-K · filed 2021-03-08 |
| 2020-09-30 | $12.33M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $12.99M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $11.61M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $12.22M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $12.87M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $13.50M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $11.35M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $12.00M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $12.67M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $13.27M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $13.87M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $14.01M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $13.88M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $11.85M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $6.01M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $7.94M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $8.82M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $8.65M 10-Q · filed 2016-08-15 | |
| 2015-12-31 | $8.34M 10-K · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |